SCHEMBL25528637

SCHEMBL25528637

CN1CCC(CNC(=O)c2cccc(CN3C(=O)c4ccc(-c5ccnc(N)c5)cc4N(C)C(=O)C3/C=C/O)c2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 5/20 0.41
MAP4K4 O95819 1/20 0.40
PARP1 P09874 1/20 0.40
GLS O94925 1/20 0.38
GSK3B P49841 4/20 0.38
EGLN1 Q9GZT9 1/20 0.37
BRD4 O60885 1/20 0.37
ROCK1 Q13464 2/20 0.36
HDAC3 O15379 5/20 0.35
HDAC4 P56524 5/20 0.35
HDAC1 Q13547 5/20 0.35
HDAC7 Q8WUI4 5/20 0.35
HDAC2 Q92769 5/20 0.35
HDAC10 Q969S8 5/20 0.35
HDAC11 Q96DB2 5/20 0.35
HDAC8 Q9BY41 5/20 0.35
HDAC6 Q9UBN7 5/20 0.35
HDAC9 Q9UKV0 5/20 0.35
HDAC5 Q9UQL6 5/20 0.35
KCNH2 Q12809 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25528196 0.90 ROCK2 (0.43) ROCK2MAP4K4PARP1GLSGSK3B
SCHEMBL25528744 0.89 ROCK2 (0.46) ROCK2MAP4K4PARP1GLSGSK3B
SCHEMBL25530636 0.89 ROCK2 (0.43) ROCK2MAP4K4PARP1GLSGSK3B
SCHEMBL25530812 0.87 GLS (0.41) ROCK2MAP4K4PARP1GLSGSK3B
SCHEMBL25528745 0.87 ROCK2 (0.42) ROCK2MAP4K4PARP1GLSGSK3B
SCHEMBL25528200 0.85 ROCK2 (0.40) ROCK2MAP4K4PARP1GSK3BROCK1
SCHEMBL25528651 0.84 ROCK2 (0.38) ROCK2MAP4K4PARP1GSK3BBRD4
SCHEMBL25528201 0.84 ROCK2 (0.39) ROCK2MAP4K4PARP1GSK3BROCK1
SCHEMBL25528649 0.84 ROCK2 (0.44) ROCK2MAP4K4PARP1GLSGSK3B
SCHEMBL25530811 0.79 BRD4 (0.49) ROCK2MAP4K4BRD4ROCK1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023093787-A1 BENZODIAZEPINE COMPOUND AND APPLICATION THEREOF AS RHO KINASE INHIBITOR 成都奥睿药业有限公司 2023-06-01 WO disclosed